Association between spinal muscular atrophy type and delayed diagnosis and the risk of spinal deformity in Indonesian patients

[1]  Y. Takeshima,et al.  Views of the General Population on Newborn Screening for Spinal Muscular Atrophy in Japan , 2021, Children.

[2]  Y. Takeshima,et al.  Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan , 2021, International journal of neonatal screening.

[3]  C. Yuan,et al.  Quality of life of children with spinal muscular atrophy and their caregivers from the perspective of caregivers: a Chinese cross-sectional study , 2020, Orphanet Journal of Rare Diseases.

[4]  S. Messina,et al.  New Treatments in Spinal Muscular Atrophy: Positive Results and New Challenges , 2020, Journal of clinical medicine.

[5]  J. Darbà.  Management and current status of spinal muscular atrophy: a retrospective multicentre claims database analysis , 2020, Orphanet Journal of Rare Diseases.

[6]  P. Thokala,et al.  The Effectiveness and Value of Treatments for Spinal Muscular Atrophy. , 2019, Journal of managed care & specialty pharmacy.

[7]  L. Servais,et al.  Clinical Evidence Supporting Early Treatment Of Patients With Spinal Muscular Atrophy: Current Perspectives , 2019, Therapeutics and clinical risk management.

[8]  Dwi Putro Widodo,et al.  Prevalensi, Spektrum Klinis dan Gambaran Neurofisiologi Kasus Neuromuskular , 2019, Sari Pediatri.

[9]  L. Servais,et al.  Nusinersen treatment of spinal muscular atrophy: current knowledge and existing gaps , 2018, Developmental medicine and child neurology.

[10]  W. Flanders,et al.  Indirect estimation of the prevalence of spinal muscular atrophy Type I, II, and III in the United States , 2017, Orphanet Journal of Rare Diseases.

[11]  W. Chung,et al.  Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care , 2017, Neuromuscular Disorders.

[12]  Y. Chien,et al.  Presymptomatic Diagnosis of Spinal Muscular Atrophy Through Newborn Screening , 2017, The Journal of pediatrics.

[13]  W. Chung,et al.  Pilot study of population-based newborn screening for spinal muscular atrophy in New York state , 2017, Genetics in Medicine.

[14]  E. Tizzano,et al.  Social/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain , 2017, Orphanet Journal of Rare Diseases.

[15]  Hanns Lochmüller,et al.  Prevalence, incidence and carrier frequency of 5q–linked spinal muscular atrophy – a literature review , 2017, Orphanet Journal of Rare Diseases.

[16]  H. Benali,et al.  Cervical Spinal Cord Atrophy Profile in Adult SMN1-Linked SMA , 2016, PloS one.

[17]  J. Kissel,et al.  Spinal Muscular Atrophy. , 2015, Neurologic clinics.

[18]  Chia-Wei Lin,et al.  Delay in Diagnosis of Spinal Muscular Atrophy: A Systematic Literature Review. , 2015, Pediatric neurology.

[19]  F. Shapiro,et al.  Simultaneous progression patterns of scoliosis, pelvic obliquity, and hip subluxation/dislocation in non-ambulatory neuromuscular patients: an approach to deformity documentation , 2015, Journal of children's orthopaedics.

[20]  W. Arnold,et al.  Spinal muscular atrophy: Diagnosis and management in a new therapeutic era , 2015, Muscle & nerve.

[21]  P. Vondracek,et al.  Health-related quality of life in children and adolescents with spinal muscular atrophy in the Czech Republic. , 2014, Pediatric neurology.

[22]  N. Nagan,et al.  Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimens , 2011, European Journal of Human Genetics.

[23]  I. Hausmanowa-Petrusewicz,et al.  Phenotype modifiers of spinal muscular atrophy: the number of SMN2 gene copies, deletion in the NAIP gene and probably gender influence the course of the disease. , 2009, Acta biochimica Polonica.

[24]  J. Melki,et al.  Spinal muscular atrophy. , 1997, Current opinion in neurology.

[25]  Teresa Foo,et al.  : SYSTEMATIC LITERATURE REVIEW , 2004 .

[26]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[27]  G. Haaker,et al.  The Application of Clinical Genetics Dovepress Proximal Spinal Muscular Atrophy: Current Orthopedic Perspective , 2022 .